Trafficking through the Rev/RRE Pathway Is Essential for Efficient Inhibition of Human Immunodeficiency Virus Type 1 by an Antisense RNA Derived from the Envelope Gene (cid:1)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 17th Conference on Retroviruses and Opportunistic Infections, 16-19 February, San Francisco, CA. The ins and outs of HIV.

  2010cited by this paper
• HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.

  2008cited by this paper
• Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells

  2008cited by this paper
• Genome-wide analysis of antisense transcription with Affymetrix exon array

  2008cited by this paper
• Antiretroviral Therapy

  2008cited by this paper
• Detection, characterization and regulation of antisense transcripts in HIV-1

  2007cited by this paper
• P bodies and the control of mRNA translation and degradation.

  2007cited by this paper
• A-to-I editing challenger or ally to the microRNA process.

  2007cited by this paper
• On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR.

  2007cited by this paper
• Ribosomal Slowdown Mediates Translational Arrest during Cellular Division

  2007cited by this paper
• Genetic therapies against HIV

  2007cited by this paper
• Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation

  2007cited by this paper
• Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

  2007cited by this paper
• Progress and prospects: RNA-based therapies for treatment of HIV infection

  2007cited by this paper
• Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products

  2006cited by this paper
• Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA

  2006cited by this paper
• The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.

  2006cited by this paper
• Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway.

  2006cited by this paper
• Translation Repression in Human Cells by MicroRNA-Induced Gene Silencing Requires RCK/p54

  2006cited by this paper
• Gene transfer in humans using a conditionally replicating lentiviral vector

  2006cited by this paper
• MicroRNAs direct rapid deadenylation of mRNA.

  2006cited by this paper
• An Update and Review of Antiretroviral Therapy

  2006cited by this paper
• Human let-7a miRNA blocks protein production on actively translating polyribosomes

  2006cited by this paper
• Evidence that microRNAs are associated with translating messenger RNAs in human cells

  2006cited by this paper
• HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated

  2006cited by this paper
• Regulating gene expression through RNA nuclear retention.

  2005cited by this paper
• Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing Resistance

  2004influential reference
• Argonaute2 Is the Catalytic Engine of Mammalian RNAi

  2004cited by this paper
• Over 20% of human transcripts might form sense-antisense pairs.

  2004cited by this paper
• Progress in antisense technology.

  2004cited by this paper
• Identification of Functional Ul snRNA-Pre-mRNA Complexes Committed to Spliceosome Assembly and Splicing

  2003cited by this paper
• Approaches for the sequence-specific knockdown of mRNA

  2003cited by this paper
• Tap and NXT promote translation of unspliced mRNA.

  2003cited by this paper
• Human Immunodeficiency Virus Type 1 Escape from RNA Interference

  2003cited by this paper
• Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue.

  2002cited by this paper
• Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1.

  2002cited by this paper
• RNA editing by adenosine deaminases that act on RNA.

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• NXT1 (p15) Is a Crucial Cellular Cofactor in TAP-Dependent Export of Intron-Containing RNA in Mammalian Cells

  2001cited by this paper
• Natural antisense transcripts are detected in different cell lines and tissues of cats infected with feline immunodeficiency virus.

  2001cited by this paper
• The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs.

  2001cited by this paper
• The specific hydrolysis of HIV-1 TAR RNA element with the anti-TAR hammerhead ribozyme: structural and functional implications.

  2001cited by this paper
• Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.

  2000cited by this paper
• Theoretical design of antisense genes with statistically increased efficacy

  2000cited by this paper
• The ins and outs of HIV Rev.

  1999cited by this paper
• HIV-1: fifteen proteins and an RNA.

  1998cited by this paper
• Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites.

  1998cited by this paper
• Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm.

  1998cited by this paper
• TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus.

  1998cited by this paper
• and Posttranscriptional Regulatory Element Not the Function of the Hepatitis B Virus Immunodeficiency Virus Rev Function but Anemia Virus Rev and Feline Leptomycin B Inhibits Equine Infectious

  1998cited by this paper
• CRM1 is an export receptor for leucine-rich nuclear export signals.

  1997cited by this paper
• Regulation of retroviral RNA export.

  1997cited by this paper
• A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA

  1997cited by this paper
• Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

  1997cited by this paper
• p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents.

  1997cited by this paper
• Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts.

  1997cited by this paper
• Application of antisense technology to therapeutics.

  1995cited by this paper
• A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.

  1994cited by this paper
• Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes

  1994cited by this paper
• Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.

  1994cited by this paper
• Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron

  1994cited by this paper
• Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat

  1994cited by this paper
• Ribozyme targeting of HIV-1 LTR.

  1994cited by this paper
• Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles

  1993cited by this paper
• Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity

  1993cited by this paper
• The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles

  1992cited by this paper
• Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products

  1992cited by this paper
• Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1.

  1991cited by this paper
• Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.

  1991cited by this paper
• Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus

  1990cited by this paper
• The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

  1989cited by this paper
• Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

  1989cited by this paper
• rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

  1989cited by this paper
• Regulation by HIV Rev depends upon recognition of splice sites.

  1989cited by this paper
• Regulation of human immunodeficiency virus env expression by the rev gene product

  1989cited by this paper
• Regulation of protein synthesis in Tetrahymena: isolation and characterization of polysomes by gel filtration and precipitation at pH 5.3.

  1982cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• No citing papers are available for this paper.